Sareen-Khanna Kapil, Papillon Joan, Wing Simon S, Cybulsky Andrey V
Department of Medicine, McGill University Health Centre Research Institute, McGill University, Montreal, Quebec, Canada.
Department of Medicine, McGill University Health Centre Research Institute, McGill University, Montreal, Quebec, Canada
Am J Physiol Renal Physiol. 2016 Nov 1;311(5):F1035-F1046. doi: 10.1152/ajprenal.00252.2016. Epub 2016 Sep 14.
Kidney cell injury may be associated with protein misfolding and induction of endoplasmic reticulum (ER) stress. Examples include complement-induced glomerular epithelial cell (GEC)/podocyte injury in membranous nephropathy and ischemia-reperfusion injury. Renal cell injury can also result from mutations in integral proteins, which lead to their misfolding and accumulation. Certain nephrin missense mutants misfold, accumulate in the ER, and induce ER stress. We examined if enhancement of ubiquitin-proteasome system function may facilitate proteostasis and confer protection against injury. Ubiquitin-specific protease 14 (Usp14) is reported to retard proteasomal protein degradation. Thus inhibition of Usp14 may enhance degradation of misfolded proteins and attenuate cell injury. In GEC, the reporter proteins GFP (a "misfolded" protein) and CD3δ (an ER-associated degradation substrate) undergo time-dependent proteasomal degradation. Complement did not affect degradation of CD3δ-yellow fluorescent protein (YFP), but accelerated degradation of GFP, and the Usp14-directed inhibitor IU1 further accelerated this degradation. Conversely, overexpression of Usp14 reduced degradation of GFP and CD3δ-YFP. In 293T cells, IU1 did not enhance degradation of disease-associated nephrin missense mutants I171N and S724C, whereas overexpression of Usp14 reduced degradation. IU1 was cytoprotective after injury induced by the ER stressor tunicamycin and in vitro ischemia-reperfusion, but did not affect complement-induced cytotoxicity. In conclusion, Usp14 controls proteasomal degradation of some misfolded proteins. In addition, a Usp14-directed inhibitor reduces cytotoxicity in the context of global protein misfolding during certain types of renal cell injury.
肾细胞损伤可能与蛋白质错误折叠及内质网(ER)应激的诱导有关。实例包括膜性肾病中补体诱导的肾小球上皮细胞(GEC)/足细胞损伤以及缺血再灌注损伤。肾细胞损伤也可能由整合蛋白的突变导致,这些突变会引起蛋白质错误折叠和积累。某些nephrin错义突变体发生错误折叠,在内质网中积累并诱导内质网应激。我们研究了增强泛素 - 蛋白酶体系统功能是否有助于蛋白质稳态并赋予细胞免受损伤的保护作用。据报道,泛素特异性蛋白酶14(Usp14)会延缓蛋白酶体的蛋白质降解。因此,抑制Usp14可能会增强错误折叠蛋白质的降解并减轻细胞损伤。在GEC中,报告蛋白绿色荧光蛋白(GFP,一种“错误折叠”的蛋白质)和CD3δ(一种内质网相关降解底物)经历时间依赖性的蛋白酶体降解。补体不影响CD3δ - 黄色荧光蛋白(YFP)的降解,但加速了GFP的降解,而Usp14定向抑制剂IU1进一步加速了这种降解。相反,Usp14的过表达降低了GFP和CD3δ - YFP的降解。在293T细胞中,IU1没有增强疾病相关的nephrin错义突变体I171N和S724C的降解,而Usp14的过表达降低了降解。IU1在内质网应激诱导剂衣霉素和体外缺血再灌注诱导的损伤后具有细胞保护作用,但不影响补体诱导的细胞毒性。总之,Usp14控制一些错误折叠蛋白质的蛋白酶体降解。此外,在某些类型肾细胞损伤期间全球蛋白质错误折叠的情况下,Usp14定向抑制剂可降低细胞毒性。